Dr Reddys Laboratories Share Price Today - Live Blog for December 03, 2025

The stock of Dr Reddys Laboratories Ltd has experienced a -0.09% drop, and it's now trading at ₹1,280.60 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

After a -0.35% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,278.15. The stock has a PE ratio of 18.5700, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.29% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,280.65 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price rallied by 0.11%, reaching the current market price of ₹1,279.70. This surge is indicative of the stock's recent positive performance.

With a remarkable 0.11% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,279.70. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.5700, while the industry's PE ratio is 33.3648.

After a notable 0.11% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,278.35. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1625 and an ROE of 16.0277%.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.04%, reaching the current market price of ₹1,276.30. This ascent signifies increased investor sentiment. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Demonstrating a commendable 0.06% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,277.30. In terms of valuation, the stock maintains a PE ratio of 18.5700, while the industry PE ratio stands at 33.3648.

Dr Reddys Laboratories Ltd's share price remained flat, currently at ₹1,276.50. This sustained performance provides investors with an opportunity to assess whether the stock aligns with their investment objectives.

Dr Reddys Laboratories Ltd's share price has fallen by -0.12%, a situation worth noting. At present, the stock is trading at ₹1,276.00. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.5700, while the industry PE ratio is 33.3648.

Dr Reddys Laboratories Ltd's stock price surged by 0.12%, reaching the current market value of ₹1,277.30 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd's share price has fallen by -0.30%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,275.05, and market participants are assessing the implications. The stock has a PE ratio of 18.5700, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.16%, reaching a current market price of ₹1,278.00. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd stock price decreased by -0.10%, with the current market value at ₹1,279.60 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd witnessed a notable 0.09% surge in its share price and is presently trading at ₹1,282.50, captivating the attention of market participants.

Dr Reddys Laboratories Ltd share price surged by 0.19%. With its current market price standing at ₹1,281.35 per share, this stock is garnering increased attention from the investment community.

The stock of Dr Reddys Laboratories Ltd is facing a -0.18% decline and is currently trading at ₹1,278.40 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.05% increase and currently trading at ₹1,280.80 per share. This upward trajectory is turning heads in the market.

Dr Reddys Laboratories Ltd's stock has surged by 0.42%, and it is currently trading at ₹1,280.00. Additionally, the stock maintains a PE ratio of 18.5700, while the industry PE is 33.3648.

Following a noteworthy 0.42% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,280.00. When it comes to valuation, this stock has a PE ratio of 18.5700, with the industry PE ratio at 33.3648.

Dr Reddys Laboratories Ltd witnessed a -0.01% decrease in its share price, and it is currently trading at ₹1,280.10. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.5700, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

After a -0.25% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,280.65. The stock has a PE ratio of 18.5700, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd witnessed a -0.21% drop in its share price and is currently trading at ₹1,280.75. With the stock's PE at 18.5700 and the industry PE at 33.3648, investors are weighing their options.

Dr Reddys Laboratories Ltd shares experienced a -0.38% reduction, with the current market price at ₹1,285.00. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.78%, reaching the current market price of ₹1,291.95. This ascent signifies increased investor sentiment. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.